BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 17498927)

  • 1. Factor analytic support for social cognition as a separable cognitive domain in schizophrenia.
    Allen DN; Strauss GP; Donohue B; van Kammen DP
    Schizophr Res; 2007 Jul; 93(1-3):325-33. PubMed ID: 17498927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a social cognition construct for the WAIS-III.
    Allen DN; Barchard KA
    Appl Neuropsychol; 2009 Oct; 16(4):262-74. PubMed ID: 20183181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery.
    Williams LM; Whitford TJ; Flynn G; Wong W; Liddell BJ; Silverstein S; Galletly C; Harris AW; Gordon E
    Schizophr Res; 2008 Feb; 99(1-3):182-91. PubMed ID: 18053688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct contribution of working memory and social comprehension failures in neuropsychological impairment in schizophrenia.
    Nestor PG; Niznikiewicz M; McCarley RW
    J Nerv Ment Dis; 2010 Mar; 198(3):206-12. PubMed ID: 20215998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms.
    Sergi MJ; Rassovsky Y; Widmark C; Reist C; Erhart S; Braff DL; Marder SR; Green MF
    Schizophr Res; 2007 Feb; 90(1-3):316-24. PubMed ID: 17141477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAIS-IV profile of cognition in schizophrenia.
    Michel NM; Goldberg JO; Heinrichs RW; Miles AA; Ammari N; McDermid Vaz S
    Assessment; 2013 Aug; 20(4):462-73. PubMed ID: 23443820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in neurocognition, theory of mind, and social functioning in patients with schizophrenic disorders: are they related?
    Bâ MB; Zanello A; Varnier M; Koellner V; Merlo MC
    J Nerv Ment Dis; 2008 Feb; 196(2):153-6. PubMed ID: 18277224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia.
    Pinkham AE; Penn DL
    Psychiatry Res; 2006 Aug; 143(2-3):167-78. PubMed ID: 16859754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits in schizophrenia on the WAIS-R NI Sentence Arrangement Subtest. Wechsler Adult Intelligence Scale-Revised Neuropsychological Inventory.
    Gard D; Harrell EH; Poreh A
    J Clin Psychol; 1999 Sep; 55(9):1085-94. PubMed ID: 10576323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construct validity of neuropsychological tests in schizophrenia.
    Allen DN; Aldarondo F; Goldstein G; Huegel SG; Gilbertson M; van Kammen DP
    Assessment; 1998 Dec; 5(4):365-74. PubMed ID: 9835660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study.
    Øie M; Sundet K; Rund BR
    Schizophr Bull; 2010 May; 36(3):557-65. PubMed ID: 18801881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis.
    Carlsson R; Nyman H; Ganse G; Cullberg J
    Acta Psychiatr Scand; 2006 Feb; 113(2):102-11. PubMed ID: 16423161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific cognitive deficits and differential domains of social functioning impairment in schizophrenia.
    Cohen AS; Forbes CB; Mann MC; Blanchard JJ
    Schizophr Res; 2006 Jan; 81(2-3):227-38. PubMed ID: 16260120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine for the treatment of cognitive impairments in people with schizophrenia.
    Buchanan RW; Conley RR; Dickinson D; Ball MP; Feldman S; Gold JM; McMahon RP
    Am J Psychiatry; 2008 Jan; 165(1):82-9. PubMed ID: 17986678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings.
    Niendam TA; Bearden CE; Rosso IM; Sanchez LE; Hadley T; Nuechterlein KH; Cannon TD
    Am J Psychiatry; 2003 Nov; 160(11):2060-2. PubMed ID: 14594759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metacognition within narratives of schizophrenia: associations with multiple domains of neurocognition.
    Lysaker PH; Dimaggio G; Buck KD; Carcione A; Nicolò G
    Schizophr Res; 2007 Jul; 93(1-3):278-87. PubMed ID: 17407806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficits of social-cognitive and social-perceptual aspects of theory of mind in remitted patients with schizophrenia: effect of residual symptoms.
    Bora E; Gökçen S; Kayahan B; Veznedaroglu B
    J Nerv Ment Dis; 2008 Feb; 196(2):95-9. PubMed ID: 18277216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizotypal traits and cognitive function in healthy adults.
    Noguchi H; Hori H; Kunugi H
    Psychiatry Res; 2008 Nov; 161(2):162-9. PubMed ID: 18849081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.